FDA Names Buhse Acting Director of OTR

Drug Industry Daily
KEYWORDS FDA / People
A A

The FDA has named Cindy Buhse acting director of its Office of Testing and Research (OTR), effective Oct. 31.

To View This Article:

Login

Subscribe To Drug Industry Daily